Phase II study with weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) and gemcitabine (GEM) in metastatic pancreas cancer

被引：0
|
作者：
Wein, A
Wehler, M
Fischer, B
Boxberger, F
Lampert, S
Riedel, C
Kastl, S
Hohenberger, W
Hahn, EG
Schneider, T
机构：
[1] Dept Internal Med 1, Erlangen, Germany
[2] Dept Surg, Erlangen, Germany
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3109
引用
收藏
页码：A612 / A612
页数：1
相关论文
共 50 条
  • [21] Toxic cardiogenic shock in a patient receiving weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin
    Wang, WS
    Hsieh, RK
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Tung, SL
    Chen, PN
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (09) : 551 - 554
  • [22] Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Hsu, C
    Kuo, SH
    Li, SJ
    Cheng, AL
    ONCOLOGY, 2005, 69 (01) : 88 - 95
  • [23] A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas
    Caroli-Bosc, FX
    Van Laethem, JL
    Michel, P
    Gay, F
    Hendlisz, A
    Forget, F
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (15) : 1828 - 1832
  • [24] Phase II study of weekly 24-h infusion of high-dose 5-fluorouracil (HD-FU) plus folinic acid (FA) in combination with mitomycin C (M) in advanced gastric cancer (AGC)
    Kretzschmar, A
    Thuss-Patience, PC
    Reichardt, P
    Hapke, G
    Hohenberger, P
    Benter, T
    Dorken, B
    Kohne, CH
    ANNALS OF ONCOLOGY, 1998, 9 : 52 - 52
  • [25] Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV)
    Roehrig, Sandra
    Wein, Axel
    Albrecht, Heinz
    Konturek, Peter C.
    Reulbach, Udo
    Maennlein, Gudrun
    Wolff, Kerstin
    Ostermeier, Nicola
    Hohenberger, Werner
    Hahn, Eckhart
    Boxberger, Frank
    MEDICAL SCIENCE MONITOR, 2010, 16 (03): : CR124 - CR131
  • [26] Phase II study in metastatic colorectal cancer patients treated with pharmacokinetically (PK) dose adjusted weekly or biweekly 5-fluorouracil (5-FU) regimes
    Link, K.
    Bertsch, T.
    Weigang-Koehler, K.
    Mueller, L.
    Ko, Y. -D.
    Stoetzer, O.
    Kunzmann, V.
    Suttmann, I.
    Roessler, M.
    Moritz, B.
    Salamone, S.
    Sonnenschein, U.
    Wilhelm, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 42 - 42
  • [27] Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
    Joulia, JM
    Pinguet, F
    Ychou, M
    Duffour, J
    Astre, C
    Bressolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 296 - 301
  • [28] Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer
    Lin, YC
    Chen, JS
    Wang, CH
    Wang, HM
    Chang, HK
    Liau, CT
    Yang, TS
    Liaw, CC
    Liu, HE
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 605 - 609
  • [29] A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
    Yeh, KH
    Cheng, AL
    Lin, MT
    Hong, RL
    Hsu, CH
    Lin, JF
    Chang, KJ
    Lee, PH
    Chen, YC
    ANTICANCER RESEARCH, 1997, 17 (5B) : 3867 - 3871
  • [30] Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid vs high dose 24h 5-FU infusion/folinic acid (FA) plus oxaliplatin(OXA) in metastatic colorectal cancer (MCRC).
    Hospers, G
    Schaapveld, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 254S - 254S
12345